Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
VAPOTHERM INC (VAPO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/17/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 05/24/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/05/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/05/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/03/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/17/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure... |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/07/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 02/24/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/23/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| Hound Partners, LLC reports a 0% stake in Vapotherm, Inc. |
| 02/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Artisan Partners Limited Partnership reports a 0% stake in Vapotherm, Inc. |
| 02/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...|
Docs:
|
"PRE-FUNDED WARRANT TO PURCHASE STOCK Company: Vapotherm, Inc., a Delaware corporation Warrant No. 2023-1 Number of Shares: [●], subject to adjustment Type/Series of Stock: Common Stock, $0.001 par value per share Warrant Price : $[●] per Share, subject to adjustment. The aggregate exercise price of this Warrant of $[●] per Share, except for a nominal exercise price of $0.001 per Share, was paid to the Company on or prior to the date of issuance of this Warrant and, consequently, no additional consideration shall be required to be paid by the Holder to effect any exercise of this Warrant. The Holder shall not be entitled to a refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the eve...",
"WARRANT TO PURCHASE STOCK Company: Vapotherm, Inc., a Delaware corporation Warrant No. 2023-1 Number of Shares: [●], subject to adjustment Type/Series of Stock: Common Stock, $0.001 par value per share Warrant Price : $[●] per Share, subject to adjustment Issue Date: February [●], 2023 Expiration Date: February [●], 2028 See also Section 5.1. THIS WARRANT CERTIFIES THAT, for good and valuable consideration, [●] or of any shares issued upon exercise hereof, “Holder”) is entitled to purchase up to the above-stated number of fully paid and non-assessable shares of the above-stated Type/Series of Stock of the above-named company at the above-stated Exercise Price, all as set forth above and as adjusted pursuant to Section 2 of this Warrant, subj...",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of February 7, 2023, among Vapotherm, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, the Company and the Purchasers are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4 of the Securities Act of 1933, as amended . WHEREAS, each Purchaser wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, the number of shares of common stock, par value $0.001 per share, of the Company set forth opposite such Purchaser’s name on hereto, which aggregate number of shares of Common Stock for all Purchasers together shall be 17,502,244 shares of Common Sto...",
"Vapotherm Announces $23 Million Private Placement EXETER, New Hampshire, February 8, 2023 / Business Wire / -- Vapotherm, Inc. , , a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that it has entered into a securities purchase agreement with a select group of institutional and accredited investors through a private placement financing for gross proceeds of approximately $23.0 million, before deducting fees to the placement agent and other offering expenses. Pursuant to the Purchase Agreement, the Company agreed to issue 17,502,244 shares of its common stock and pre-funded warrants to purchase up t..." |
|
| 02/08/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Vapotherm Reports Preliminary Fourth Quarter and Full Year 2022 Results and Year-End Cash Balance EXETER, New Hampshire, February 8, 2023 / Business Wire / -- Vapotherm, Inc. , , a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced preliminary unaudited fourth quarter and full year 2022 net results. Preliminary Fourth Quarter and Full Year 2022 Financial Results For the fourth quarter of 2022, the Company expects net revenue to be in the range of $18.4 million to $18.7 million. For the fourth quarter of 2022, the Company expects gross margin to be in the range of 27% to 28%. For the fourth quarter of ..." |
|
| 02/03/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 01/30/2023 |
SC 13G
| BARCLAYS PLC reports a 6.5% stake in Vapotherm, Inc. |
| 01/24/2023 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 5.6% stake in VAPOTHERM, INC. |
| 12/08/2022 |
SC 13D
| Army Joseph reports a 6.5% stake in Vapotherm, Inc. |
| 12/06/2022 |
8-K
| Quarterly results |
| 12/01/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/22/2022 |
8-K
| Quarterly results |
| 11/02/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/02/2022 |
8-K
| Quarterly results |
|
|
|